INVO Bioscience, Inc. (NASDAQ:INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device
Most countries around the world in 2022 faced headwinds that slowed down their respective economies. Whether it was inflation, issues from COVID-19 or supply-chain problems caused by the Russia-Ukraine war, it was a tough year economically.
Well, apparently for everyone but China.